To add or not to add LH: Comments on a recent commentary

Reproductive BioMedicine Online

Volumn 12, Issue 3, 2006, Pages 284-285

  Humaidan, Peter ^a  

^a VIBORG HOSPITAL   (Denmark)

Author keywords

Endogenous LH; IVF; Ovarian stimulation; Recombinant FSH; Recombinant LH

Indexed keywords

GONADORELIN AGONIST; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FERTILIZATION IN VITRO; HORMONE ACTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; IMMUNOREACTIVITY; LUTEINIZING HORMONE BLOOD LEVEL; OVULATION INDUCTION; PREGNANCY OUTCOME; TREATMENT OUTCOME;

EID: 33645074915     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60998-4     Document Type: Note

References (10)

1. De Placido G, Alviggi C, Perino A et al. 2005 Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomised controlled trial. Human Reproduction 20, 390-396.
2. Fleming R, Lloyd F, Herbert M et al. 1998 Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Human Reproduction 13, 1788-1792.
3. Huhtaniemi I, Jiang M, Nilsson C et al. 1999 Mutations and polymorphisms in gonadotropin genes. Molecular and Cellular Endocrinology 25, 89-94.
4. Humaidan P, Bungum M, Bungurn L et al. 2004 Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reproductive BioMedicine Online 8, 635-643.
5. Humaidan P, Bungum L, Bungum M et al. 2002 Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Human Reproduction 17, 2016-2021.
6. Jiang M, Pakarinen P, Zhang FP 1999 A common polymorphic allele of the human luteinizing hormone beta-subunit gene: additional mutations and differential function of the promoter sequence. Human Molecular Genetics 8, 2037-2046.
7. Kol S 2005 To add or not to add LH: consideration of LH concentration changes in individual patients. Reproductive BioMedicine Online 11, 664-666.
8. Marrs R, Meldrum D, Muasher S et al. 2004 Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reproductive BioMedicine Online 8, 175-182.
9. Ropelato MG, Garcia-Rudaz MC, Castro-Fernandez C 1999 A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 84 4629-4636.
10. Westergaard, LG, Laursen, SB, Yding Andersen C 2000 Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in IVF treated normogonadotropic women. Human Reproduction 15, 1003-1008.